 ARLINGTON, Mass., Aug. 04, 2022 GLOBE NEWSWIRE -- Kala Pharmaceuticals, Inc. NASDAQ:KALA, a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in August 2022: 